Shah Rutul R sold $225K of PGEN
Shah Rutul R (Chief Operating Officer) sold 32,739 shares of PRECIGEN, INC. (PGEN) at $6.86 ($0.22M total) on 2026-08-06 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale size, price ($6.86), and that it was executed under a pre-arranged 10b5-1 plan by the COO.
Market read
Traders may note the insider sale for sentiment, but it is unlikely to drive price without accompanying fundamental news.
What to watch
The filing does not indicate changes in business outlook, guidance, or trial/regulatory milestones; it only documents the transaction mechanics and post-sale holdings.
Background
The article is an SEC Form 4 insider transaction disclosure for Precigen, Inc. (PGEN).
Ticker impact
Precigen COO Shah Rutul R sold 32,739 shares in an open-market transaction at $6.86 on 2026-08-06 under a 10b5-1 plan.
Likely limited, short-lived impact unless paired with other company-specific catalysts.
Form 4 provides transaction details and confirms a pre-arranged 10b5-1 plan, which typically reduces interpretive signal versus discretionary selling.
Market effects
No clear sector read-through from a single 10b5-1 insider sale at a biotech issuer.
None.
None.
Counterpoint
A 10b5-1 sale can be purely planned liquidity, so the market may overreact if it treats it as a bearish signal.
Key entities
- issuerPRECIGEN, INC.
Company whose insider transaction is disclosed on Form 4.
- insiderShah Rutul R
Chief Operating Officer who sold shares under a 10b5-1 plan.
